Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Public ClinicalTrials.gov record NCT06164743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery
Study identification
- NCT ID
- NCT06164743
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- VivaVision Biotech, Inc
- Industry
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- VVN461 Ophthalmic Solution 1.0% Drug
- VVN461 Ophthalmic Solution 0.5% Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 10, 2024
- Primary completion
- May 14, 2024
- Completion
- May 14, 2024
- Last update posted
- Jun 9, 2025
2024
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United Medical Research Institute | Inglewood | California | 90301 | — |
| North Bay Eye Associates | Petaluma | California | 94954 | — |
| Martel Eye Associates | Rancho Cordova | California | 95670 | — |
| ICON Eye Care | Grand Junction | Colorado | 81501 | — |
| Levenson Eye Associates | Jacksonville | Florida | 32204 | — |
| Comprehensive Eye Care, Ltd | Washington | Missouri | 63090 | — |
| Center For Sight - Las Vegas | Las Vegas | Nevada | 89145 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Keystone Research | Austin | Texas | 78731 | — |
| Houston Eye Associates | Houston | Texas | 77708 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06164743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06164743 live on ClinicalTrials.gov.